drugset / Trial / NCT02951962
A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin
Non-randomizedCrossoverOpen-labelTreatment
Summary
This is a phase 1, open label, two-cohort, single-sequence, crossover study
Timeline
- Start
- 2016-08
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |